CERo Therapeutics Warrants
CEROW
CEROW was delisted on the 30th of October, 2025.
34 hedge funds and large institutions have $110K invested in CERo Therapeutics Warrants in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 4 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
8% less funds holding
Funds holding: 37 → 34 (-3)
74% less capital invested
Capital invested by funds: $425K → $110K (-$315K)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Capital
New York
|
+$7.77K |
| 2 |
Walleye Trading
New York
|
+$4.37K |
| 3 |
CAC
Cowen and Company
New York
|
+$2.84K |
| 4 |
CS
Clear Street
New York
|
+$70 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$29 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$9.6K |
| 2 |
ICM
Ionic Capital Management
New York
|
-$5.48K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.24K |
| 4 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$1.19K |
| 5 |
FTUS
Flow Traders U.S.
New York
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Calamos Advisors
Naperville,
Illinois
| $250 | – | – | – |
|
|
DCM
27
Dupont Capital Management
Wilmington,
Delaware
| $250 | – | – | – |
|
|
SRF
28
Silver Rock Financial
Los Angeles,
California
| $246 | – | – | – |
|
|
EAM
29
Exos Asset Management
New York
| $74 | – | – | – |
|
|
AA
30
Ancora Advisors
Cleveland,
Ohio
| $50 | – | – | – |
|
|
31
Bank of America
Charlotte,
North Carolina
| $14 | +$29 | +500 | +250% |
|
|
RCM
32
Robinson Capital Management
Grosse Pointe Farms,
Michigan
| $7 | +$21 | +355 | New |
|
|
PA
33
Pineridge Advisors
St. Charles,
Missouri
| $3 | – | – | – |
|
|
TRCT
34
Tower Research Capital (TRC)
New York
| $2 | – | – | – |
|
|
ICM
35
Ionic Capital Management
New York
| – | -$5.48K | -80,300 | Closed |
|
|
FTUS
36
Flow Traders U.S.
New York
| – | -$1K | -17,967 | Closed |
|
|
37
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$1.24K | -13,945 | Closed |
|
|
CSS
38
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$716 | -10,500 | Closed |
|
|
HF
39
HRT Financial
New York
| – | -$12 | -212 | -0.6% |
|
CEROW Hedge Fund Activity: Q2 2024 in Review
34 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in CERo Therapeutics Warrants (CEROW) for Q2 2024, worth a combined $110K — down 74% from $425K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of CEROW and 1 opened new positions — a net loss of 3 holders — while 5 trimmed existing stakes and 5 added.
The largest buyer was Walleye Capital, adding an estimated $7.77K. The largest seller was Periscope Capital, cutting an estimated $9.6K.
- 34 institutional investors held CERo Therapeutics Warrants (CEROW) as of Q2 2024, down from 37 in Q1 2024.
- Funds reported $110K of CERo Therapeutics Warrants stock for Q2 2024, down 74% quarter-over-quarter.
- 1 fund opened new CERo Therapeutics Warrants positions in Q2 2024 and 4 closed out, a net change of -3 holders.
- The largest CERo Therapeutics Warrants buyer in Q2 2024 was Walleye Capital, an estimated $7.77K added.
- The largest CERo Therapeutics Warrants seller in Q2 2024 was Periscope Capital, an estimated $9.6K sold.
Based on aggregated 13F filings for Q2 2024.